Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis

By sjmartinez • April 6, 2023

Ballav S, Bhosale M, Lokhande KB, Paul MK, Padhye S, Swamy KV, Ranjan A, Basu S. Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis. Adv Biol (Weinh). 2023 Apr 5:e2300036. doi: 10.1002/adbi.202300036. Epub ahead of print. PMID: 37017501.

Tags: EMT, Lung cancer, Partial agonist, PPAR-γ, Publications, Pulmonary, Critical Care & Sleep Medicine, Quercetin derivatives, Schiff base

Consensus-based Recommendations on the Management of Immunosuppression After Squamous Cell Carcinoma Diagnosis in Kidney Transplant Recipients: An International Delphi Consensus Statement

Whitley MJ, Wang JX, Chapman J, de Vries APJ, Chandran S, Glennon CM, Madariaga HM, Carroll RP, Booth J, Concepcion B, Couzi L, De Serres[...]

A normal BNP does not reliably exclude pulmonary hypertension in interstitial lung disease

Brownstein AJ, Lliang L, Channick R, Kim A, Saggar R. A normal BNP does not reliably exclude pulmonary hypertension in interstitial lung disease. Eur Respir[...]

Indefinite for dysplasia in Barrett’s esophagus: definitely worth your attention

Muthusamy VR. Indefinite for dysplasia in Barrett's esophagus: definitely worth your attention. Gastrointest Endosc. 2026 Jan;103(1):84-86. doi: 10.1016/j.gie.2025.06.024. PMID: 41412705.